419 related articles for article (PubMed ID: 9500558)
1. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus.
Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG
Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558
[TBL] [Abstract][Full Text] [Related]
2. A double blind study of the effect of acipimox on serum lipids, blood glucose control and insulin action in non-obese patients with type 2 diabetes mellitus.
Fulcher GR; Catalano C; Walker M; Farrer M; Thow J; Whately-Smith CR; Alberti KG
Diabet Med; 1992 Dec; 9(10):908-14. PubMed ID: 1478035
[TBL] [Abstract][Full Text] [Related]
3. Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period.
Worm D; Henriksen JE; Vaag A; Thye-Rønn P; Melander A; Beck-Nielsen H
J Clin Endocrinol Metab; 1994 Mar; 78(3):717-21. PubMed ID: 8126147
[TBL] [Abstract][Full Text] [Related]
4. Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes.
Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Eriksson J; Taskinen MR
Diabet Med; 1993 Dec; 10(10):950-7. PubMed ID: 8306591
[TBL] [Abstract][Full Text] [Related]
5. Acipimox attenuates hypertriglyceridemia in dyslipidemic noninsulin dependent diabetes mellitus patients without perturbation of insulin sensitivity and glycemic control.
Shih KC; Kwok CF; Hwu CM; Hsiao LC; Li SH; Liu YF; Ho LT
Diabetes Res Clin Pract; 1997 May; 36(2):113-9. PubMed ID: 9229195
[TBL] [Abstract][Full Text] [Related]
6. The effect of acipimox in patients with type 2 diabetes and persistent hyperlipidaemia.
Dean JD; McCarthy S; Betteridge DJ; Whately-Smith C; Powell J; Owens DR
Diabet Med; 1992; 9(7):611-5. PubMed ID: 1511566
[TBL] [Abstract][Full Text] [Related]
7. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effect of decreasing nonesterified fatty acid levels with acipimox in hyperthyroid patients.
Park KS; Kim CH; Lee MK; Shin CS; Park DJ; Kim SY; Cho BY; Lee HK
Metabolism; 1999 Oct; 48(10):1318-21. PubMed ID: 10535397
[TBL] [Abstract][Full Text] [Related]
10. Effects of chloroquine on the dyslipidemia of non-insulin-dependent diabetes mellitus.
Powrie JK; Shojaee-Moradie F; Watts GF; Smith GD; Sönksen PH; Jones RH
Metabolism; 1993 Apr; 42(4):415-9. PubMed ID: 8487662
[TBL] [Abstract][Full Text] [Related]
11. Effects of prolonged Acipimox treatment on glucose and lipid metabolism and on in vivo insulin sensitivity in patients with non-insulin dependent diabetes mellitus.
Vaag AA; Beck-Nielsen H
Acta Endocrinol (Copenh); 1992 Oct; 127(4):344-50. PubMed ID: 1449046
[TBL] [Abstract][Full Text] [Related]
12. Improvement of lipoprotein lipid composition in type II diabetic patients with concomitant hyperlipoproteinemia by acipimox treatment. Results of a multicenter trial.
Koev D; Zlateva S; Susic M; Babic D; Profozic V; Skrabalo Z; Langrová H; Cvrkalová AL; Rajecová E; Klimes I
Diabetes Care; 1993 Sep; 16(9):1285-90. PubMed ID: 8404433
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects.
Fulcher GR; Walker M; Catalano C; Agius L; Alberti KG
Diabetes; 1992 Nov; 41(11):1400-8. PubMed ID: 1397716
[TBL] [Abstract][Full Text] [Related]
14. Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes.
Paolisso G; Tagliamonte MR; Rizzo MR; Gualdiero P; Saccomanno F; Gambardella A; Giugliano D; D'Onofrio F; Howard BV
Diabetologia; 1998 Oct; 41(10):1127-32. PubMed ID: 9794097
[TBL] [Abstract][Full Text] [Related]
15. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
[TBL] [Abstract][Full Text] [Related]
16. Short-term efficacy and tolerability of combination therapy with lovastatin and acipimox in Chinese patients with type 2 diabetes mellitus and mixed dyslipidemia.
Ko GT; Mak TW; Yeung VT; Chan DC; Lam CW; Tsang LW; Chow CC; Cockram CS
J Clin Pharmacol; 1998 Oct; 38(10):912-7. PubMed ID: 9807971
[TBL] [Abstract][Full Text] [Related]
17. The effects of lipid lowering drugs on metabolic control and lipoprotein composition in type 2 diabetic patients with mild hyperlipidaemia.
Stewart MW; Dyer RG; Alberti KG; Laker MF
Diabet Med; 1995 Mar; 12(3):250-7. PubMed ID: 7758262
[TBL] [Abstract][Full Text] [Related]
18. Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM.
Saloranta C; Taskinen MR; Widen E; Härkönen M; Melander A; Groop L
Diabetes; 1993 Nov; 42(11):1559-66. PubMed ID: 8405695
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.
Farrer M; Winocour PH; Evans K; Neil HA; Laker MF; Kesteven P; Alberti KG
Diabetes Res Clin Pract; 1994 Mar; 23(2):111-9. PubMed ID: 8070302
[TBL] [Abstract][Full Text] [Related]
20. Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia.
Hadigan C; Liebau J; Torriani M; Andersen R; Grinspoon S
J Clin Endocrinol Metab; 2006 Nov; 91(11):4438-44. PubMed ID: 16940448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
